On May 19, 2026, Kopran Ltd's board will discuss their Q4 FY26 results, including a possible dividend recommendation and reopening of the trading window following the announcement.

Kopran Limited has received approval from the National Company Law Tribunal (NCLT) to hold meetings regarding its planned merger with Kopran Laboratories. The NCLT's directive, dated April 9, 2026, can be found on Kopran's website for stakeholders to review.